Egalet has built a robust pipeline built around products developed using its Guardian® Technology, and through business development. The Company licensed and acquired OXAYDO and SPRIX Nasal Spray.
AD = abuse-deterrent; ER = extended release.
*Management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.
OXAYDO is a registered trademark of Egalet Corporation.
SPRIX is a registered trademark of Egalet Corporation.
SPRIX is a registered trademark of Egalet Corporation.